These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19467309)

  • 1. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
    Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
    Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
    Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
    J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
    Allard E; Jarnet D; Vessières A; Vinchon-Petit S; Jaouen G; Benoit JP; Passirani C
    Pharm Res; 2010 Jan; 27(1):56-64. PubMed ID: 19908129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
    Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
    Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.
    Clavreul A; Montagu A; Lainé AL; Tétaud C; Lautram N; Franconi F; Passirani C; Vessières A; Montero-Menei CN; Menei P
    Int J Nanomedicine; 2015; 10():1259-71. PubMed ID: 25709447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
    Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
    Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
    Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
    Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
    Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptation of lipid nanocapsule formulations for blood administration in animals.
    Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
    Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocapsules: a new platform for nanomedicine.
    Huynh NT; Passirani C; Saulnier P; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules.
    Lainé AL; Clavreul A; Rousseau A; Tétaud C; Vessieres A; Garcion E; Jaouen G; Aubert L; Guilbert M; Benoit JP; Toillon RA; Passirani C
    Nanomedicine; 2014 Nov; 10(8):1667-77. PubMed ID: 24842766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
    Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
    Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.
    David S; Montier T; Carmoy N; Resnier P; Clavreul A; Mével M; Pitard B; Benoit JP; Passirani C
    J Gene Med; 2012 Dec; 14(12):769-75. PubMed ID: 23143656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
    Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
    Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
    Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
    Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
    Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
    Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure.
    Idlas P; Lepeltier E; Bastiat G; Pigeon P; McGlinchey MJ; Lautram N; Vessières A; Jaouen G; Passirani C
    Langmuir; 2023 Feb; 39(5):1885-1896. PubMed ID: 36693216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
    Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
    Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.